Cargando…
Immunosuppressive niche engineering at the onset of human colorectal cancer
The evolutionary dynamics of tumor initiation remain undetermined, and the interplay between neoplastic cells and the immune system is hypothesized to be critical in transformation. Colorectal cancer (CRC) presents a unique opportunity to study the transition to malignancy as pre-cancers (adenomas)...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979971/ https://www.ncbi.nlm.nih.gov/pubmed/35379804 http://dx.doi.org/10.1038/s41467-022-29027-8 |
_version_ | 1784681294836269056 |
---|---|
author | Gatenbee, Chandler D. Baker, Ann-Marie Schenck, Ryan O. Strobl, Maximilian West, Jeffrey Neves, Margarida P. Hasan, Sara Yakub Lakatos, Eszter Martinez, Pierre Cross, William C. H. Jansen, Marnix Rodriguez-Justo, Manuel Whelan, Christopher J. Sottoriva, Andrea Leedham, Simon Robertson-Tessi, Mark Graham, Trevor A. Anderson, Alexander R. A. |
author_facet | Gatenbee, Chandler D. Baker, Ann-Marie Schenck, Ryan O. Strobl, Maximilian West, Jeffrey Neves, Margarida P. Hasan, Sara Yakub Lakatos, Eszter Martinez, Pierre Cross, William C. H. Jansen, Marnix Rodriguez-Justo, Manuel Whelan, Christopher J. Sottoriva, Andrea Leedham, Simon Robertson-Tessi, Mark Graham, Trevor A. Anderson, Alexander R. A. |
author_sort | Gatenbee, Chandler D. |
collection | PubMed |
description | The evolutionary dynamics of tumor initiation remain undetermined, and the interplay between neoplastic cells and the immune system is hypothesized to be critical in transformation. Colorectal cancer (CRC) presents a unique opportunity to study the transition to malignancy as pre-cancers (adenomas) and early-stage cancers are frequently resected. Here, we examine tumor-immune eco-evolutionary dynamics from pre-cancer to carcinoma using a computational model, ecological analysis of digital pathology data, and neoantigen prediction in 62 patient samples. Modeling predicted recruitment of immunosuppressive cells would be the most common driver of transformation. As predicted, ecological analysis reveals that progressed adenomas co-localized with immunosuppressive cells and cytokines, while benign adenomas co-localized with a mixed immune response. Carcinomas converge to a common immune “cold” ecology, relaxing selection against immunogenicity and high neoantigen burdens, with little evidence for PD-L1 overexpression driving tumor initiation. These findings suggest re-engineering the immunosuppressive niche may prove an effective immunotherapy in CRC. |
format | Online Article Text |
id | pubmed-8979971 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-89799712022-04-20 Immunosuppressive niche engineering at the onset of human colorectal cancer Gatenbee, Chandler D. Baker, Ann-Marie Schenck, Ryan O. Strobl, Maximilian West, Jeffrey Neves, Margarida P. Hasan, Sara Yakub Lakatos, Eszter Martinez, Pierre Cross, William C. H. Jansen, Marnix Rodriguez-Justo, Manuel Whelan, Christopher J. Sottoriva, Andrea Leedham, Simon Robertson-Tessi, Mark Graham, Trevor A. Anderson, Alexander R. A. Nat Commun Article The evolutionary dynamics of tumor initiation remain undetermined, and the interplay between neoplastic cells and the immune system is hypothesized to be critical in transformation. Colorectal cancer (CRC) presents a unique opportunity to study the transition to malignancy as pre-cancers (adenomas) and early-stage cancers are frequently resected. Here, we examine tumor-immune eco-evolutionary dynamics from pre-cancer to carcinoma using a computational model, ecological analysis of digital pathology data, and neoantigen prediction in 62 patient samples. Modeling predicted recruitment of immunosuppressive cells would be the most common driver of transformation. As predicted, ecological analysis reveals that progressed adenomas co-localized with immunosuppressive cells and cytokines, while benign adenomas co-localized with a mixed immune response. Carcinomas converge to a common immune “cold” ecology, relaxing selection against immunogenicity and high neoantigen burdens, with little evidence for PD-L1 overexpression driving tumor initiation. These findings suggest re-engineering the immunosuppressive niche may prove an effective immunotherapy in CRC. Nature Publishing Group UK 2022-04-04 /pmc/articles/PMC8979971/ /pubmed/35379804 http://dx.doi.org/10.1038/s41467-022-29027-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Gatenbee, Chandler D. Baker, Ann-Marie Schenck, Ryan O. Strobl, Maximilian West, Jeffrey Neves, Margarida P. Hasan, Sara Yakub Lakatos, Eszter Martinez, Pierre Cross, William C. H. Jansen, Marnix Rodriguez-Justo, Manuel Whelan, Christopher J. Sottoriva, Andrea Leedham, Simon Robertson-Tessi, Mark Graham, Trevor A. Anderson, Alexander R. A. Immunosuppressive niche engineering at the onset of human colorectal cancer |
title | Immunosuppressive niche engineering at the onset of human colorectal cancer |
title_full | Immunosuppressive niche engineering at the onset of human colorectal cancer |
title_fullStr | Immunosuppressive niche engineering at the onset of human colorectal cancer |
title_full_unstemmed | Immunosuppressive niche engineering at the onset of human colorectal cancer |
title_short | Immunosuppressive niche engineering at the onset of human colorectal cancer |
title_sort | immunosuppressive niche engineering at the onset of human colorectal cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979971/ https://www.ncbi.nlm.nih.gov/pubmed/35379804 http://dx.doi.org/10.1038/s41467-022-29027-8 |
work_keys_str_mv | AT gatenbeechandlerd immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer AT bakerannmarie immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer AT schenckryano immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer AT stroblmaximilian immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer AT westjeffrey immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer AT nevesmargaridap immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer AT hasansarayakub immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer AT lakatoseszter immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer AT martinezpierre immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer AT crosswilliamch immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer AT jansenmarnix immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer AT rodriguezjustomanuel immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer AT whelanchristopherj immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer AT sottorivaandrea immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer AT leedhamsimon immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer AT robertsontessimark immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer AT grahamtrevora immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer AT andersonalexanderra immunosuppressivenicheengineeringattheonsetofhumancolorectalcancer |